Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-2-17
pubmed:abstractText
The long-term prognosis of immunoglobulin A nephropathy (IgAN) is reportedly poor. In Japan, tonsillectomy-steroid pulse therapy has frequently been used for treatment of early IgAN, with favorable outcomes. However, steroid usage is sometimes limited due to adverse reactions. To reduce the total dose of steroids, we have been using mizoribine (MZR) in combination with tonsillectomy-steroid pulse therapy since 2004. Here we report a retrospective evaluation of our protocol outcome.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-10574997, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-10903900, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-11231363, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-11549900, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-11576876, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-14586726, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-14694168, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-14726626, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-15550753, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-17699253, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-18508946, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-19339088, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-2007290, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-4180586, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-8325022, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-9366383, http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-9609465
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1437-7799
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
73-8
pubmed:dateRevised
2011-7-27
pubmed:meshHeading
pubmed-meshheading:20972695-Adolescent, pubmed-meshheading:20972695-Adult, pubmed-meshheading:20972695-Female, pubmed-meshheading:20972695-Glomerular Filtration Rate, pubmed-meshheading:20972695-Glomerulonephritis, IGA, pubmed-meshheading:20972695-Glucocorticoids, pubmed-meshheading:20972695-Humans, pubmed-meshheading:20972695-Immunosuppressive Agents, pubmed-meshheading:20972695-Japan, pubmed-meshheading:20972695-Kidney, pubmed-meshheading:20972695-Kidney Failure, Chronic, pubmed-meshheading:20972695-Kidney Function Tests, pubmed-meshheading:20972695-Male, pubmed-meshheading:20972695-Methylprednisolone, pubmed-meshheading:20972695-Middle Aged, pubmed-meshheading:20972695-Pulse Therapy, Drug, pubmed-meshheading:20972695-Remission Induction, pubmed-meshheading:20972695-Retrospective Studies, pubmed-meshheading:20972695-Ribonucleosides, pubmed-meshheading:20972695-Tonsillectomy, pubmed-meshheading:20972695-Treatment Outcome, pubmed-meshheading:20972695-Young Adult
pubmed:year
2011
pubmed:articleTitle
Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function.
pubmed:affiliation
Division of Neurology, Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan. tomohiro@nms.ac.jp
pubmed:publicationType
Journal Article